GlassScriptPhysician profile
Mimi Leong
NPI 1295830560
$986.07
in general payments reported to CMS, 2019-2025
12 companies · $20.03 in 2025
The $20.03 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $105 · 2021: $200 · 2022: $83.50 · 2023: $391 · 2024: $24.46 · 2025: $20.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $435.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $386.20 | 2019-2024 | Puraply, Puraply Am |
| Imbed Biosciences INC. | $180.18 | 2023 | |
| Smith+Nephew, INC. | $166.90 | 2019-2023 | Stravix, Grafix, Oasis |
| Musculoskeletal Transplant Foundation INC. | $66.83 | 2019-2021 | |
| Kerecis Limited | $37.37 | 2021 | |
| Sientra, INC. | $32.80 | 2022 | |
| 3m Company | $26.42 | 2019 | |
| Tela Bio, INC. | $21.95 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Integra Lifesciences Corporation | $20.03 | 2025 | Cytal |
| Urgo Medical North America, LLC | $19.91 | 2023 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Osiris Therapeutics INC. | $15.42 | 2019 | |
| Endo Pharmaceuticals INC. | $12.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mimi Leong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.